View Post

Bard1 Life Sciences (ASX:BD1) reveals tech’s efficiency in detecting breast cancer

In Clinical Studies News by Barbara Jacoby

By: Samantha Goerling From: themarketherald.com.au Australian diagnostics company Bard1 Life Sciences (BD1) has revealed its SubB2M technology can detect all stages of breast cancer from a blood sample. Research completed by the Griffith University’s Institute for Glycomics found the technology could detect the cancer with 100 per cent specificity and 95 per cent sensitivity. “A non-invasive, accurate and reliable blood test …

View Post

New technology detects breast cancer using tears

In In The News by Barbara Jacoby

Source: Kobe University From: news-medical.net Kobe University and System Instruments Co., Ltd. researchers have developed TearExo®; new technology to detect breast cancer using the exosomes found in tears as biomarkers. Exosomes are a subtype of extracellular vesicles. Research team members included Professor TAKEUCHI Toshifumi (Kobe University Graduate School of Engineering), Project Professor TANINO Hirokazu and Professor SASAKI Ryohei (both of …